Sigma Capital Management’s Gilead Sciences GILD Stock Holding History

Sigma Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,000	Closed	-$1.77M	–	46
2014 Q1	$1.77M	Buy	+25,000	New	+$1.96M	0.09%	138
2013 Q4	–	Sell	-70,000	Closed	-$4.4M	–	202
2013 Q3	$4.4M	Sell	70,000 -295,000	-81%	-$17.6M	0.18%	145
2013 Q2	$18.7M	Buy	+365,000	New	+$19M	0.86%	39

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sigma Capital Management's GILD Position: Q2 2014 in Review

Sigma Capital Management sold out of Gilead Sciences (GILD) in Q2 2014, closing a stake of 25,000 shares — an estimated $1.77M sold.

Sigma Capital Management first reported a position in GILD in Q2 2013 and held it in 3 quarters. The position peaked at $18.7M in Q2 2013. 1,262 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

Sigma Capital Management reported no remaining Gilead Sciences position as of Q2 2014 after selling out during the quarter.
Sigma Capital Management sold 25,000 Gilead Sciences shares in Q2 2014, an estimated $1.77M.
Sigma Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 3 quarters.
Sigma Capital Management's Gilead Sciences position peaked at $18.7M in Q2 2013.
1,262 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Sigma Capital Management's 13F filing for Q2 2014.